Thymosin beta-4 is the most prevalent of the cytoplasmic G-actin binding proteins belonging to the highly conserved thymosin beta family. Known to bind actin monomers, Thymosin beta-4 sequesters G-actin in a manner that prevents actin polymerization. Thymosin beta-4 plays several important roles including induction of tissue remodeling, wound healing in both cell and tissue injuries, and cell differentiation via mechanisms that have yet to be fully elucidated. It is involved in the regulation of the cytoskeleton, and thereby influences an array of cellular processes. Within the brain, Thymosin beta-4 is associated with the neurite extension and migration of neurons. Expression has been observed in various hemopoietic and lymphoid malignant cell lines.
This report contains market size and forecasts of Thymosin Beta 4 Antibody in global, including the following market information:
Global Thymosin Beta 4 Antibody Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Thymosin Beta 4 Antibody Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Thymosin Beta 4 Antibody companies in 2021 (%)
The global Thymosin Beta 4 Antibody market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Human Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Thymosin Beta 4 Antibody include ProSci, Feldan, Abbiotec, Genecopoeia, Abcam, One World Lab (OWL), OriGene Technologies, Biorbyt and Fisher Scientific, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Thymosin Beta 4 Antibody manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Thymosin Beta 4 Antibody Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Thymosin Beta 4 Antibody Market Segment Percentages, by Type, 2021 (%)
Human
Animal
Global Thymosin Beta 4 Antibody Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Thymosin Beta 4 Antibody Market Segment Percentages, by Application, 2021 (%)
ELISA
Immunohistochemistry
Global Thymosin Beta 4 Antibody Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Thymosin Beta 4 Antibody Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Thymosin Beta 4 Antibody revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Thymosin Beta 4 Antibody revenues share in global market, 2021 (%)
Key companies Thymosin Beta 4 Antibody sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Thymosin Beta 4 Antibody sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
ProSci
Feldan
Abbiotec
Genecopoeia
Abcam
One World Lab (OWL)
OriGene Technologies
Biorbyt
Fisher Scientific
Novus Biologicals
LifeSpan Biosciences